eyeforpharma Barcelona goes VIRTUAL

eyeforpharma Barcelona goes VIRTUAL

Spotlight: Advertorial from Pf Partners Hi Covid-19 has undoubtedly created one of the most challenging environments of the modern era. Together, we must step up to...
Image of SHerlock Holmes type character with a large magnifying glass to show CMA launches COVID-19 taskforce to monitor market practices

CMA launches COVID-19 taskforce to monitor market practices

The CMA is launching a COVID-19 taskforce to tackle negative impacts within its remit of the coronavirus pandemic. The outbreak of Covid-19 is an unprecedented...
Image of seesaw with a lightbulb on the left and money on the right to show LifeArc launches £10m COVID-19 clinical research fund

LifeArc launches £10m COVID-19 clinical research fund

LifeArc, a UK-based medical research charity, has created a £10m COVID-19 clinical research fund to support research to accelerate the development and testing of...
Image of lab equipment to show Synairgen to start trial of SNG001 in COVID-19

Synairgen to start trial of SNG001 in COVID-19

Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Image of a microscope and papers to show Study of siltuximab for treating COVID-19 serious respiratory complications initiated

Study of siltuximab for treating COVID-19 serious respiratory complications initiated

A study of siltuximab for treating COVID-19 serious respiratory complications has been initiated. EUSA Pharma has announced the initiation of the Papa Giovanni XXIII Hospital...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

First coronavirus vaccine clinical trial starts

The first coronavirus vaccine clinical trial has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The Phase 1 clinical trial is...
Image of a hand with germs on it to show Roche COVID-19 test gets emergency FDA authorisation

FDA emergency authorisation for Roche’s COVID-19 test

Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Image of scientists standing around a giant magnifying glass with books, charts and research to show Elsevier gives full access to its coronavirus information centre content

Elsevier gives full access to its coronavirus information centre content

Elsevier is giving full access to its content on its coronavirus information centre for PubMed Central and other public health databases, such as the...
Image of raised blocks with lots of research and scientific items on to show Free scientific advice for coronavirus medicine or vaccine developers

Free scientific advice for coronavirus medicine or vaccine developers

The European Medicines Agency is offering free scientific advice to coronavirus medicine or vaccine developers. EMA is providing full fee waivers for scientific advice applications from...
Image of Pf Awards 2020 logo to indicate pf awards 2020 coronavirus update

Pf Awards 2020 coronavirus update 

It is with deepest regret that we have taken the decision to cancel the Pf Awards 2020. Please see our updated statement. With the Pf...

Latest articles

Promising Innovative Medicine designation for Novartis' targeted radioligand theragnostics in prostate cancer

Promising Innovative Medicine designation for Novartis’ targeted radioligand theragnostics in prostate cancer

Novartis has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted Promising Innovative Medicine (PIM) designation for 177Lu-PSMA-617, an investigational radioligand...
Positive Phase III results for Lynparza plus abiraterone in metastatic prostate cancer

Positive Phase III results for Lynparza plus abiraterone in metastatic prostate cancer

Positive high-level results from the PROpel Phase III trial have shown that AstraZeneca and MSD’s Lynparza (olaparib), in combination with abiraterone, demonstrated a significant improvement in...
AstraZeneca invests in Imperial College spin-off, VaxEquity

AstraZeneca invests in Imperial College spin-off VaxEquity

AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery, development and commercialisation of the proprietary self-amplifying RNA (saRNA) therapeutics platform developed...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
UK market access and the opportunities for pharma

UK market access and the opportunities for pharma

The UK market access environment faces a time of change – the result of the convergence of several major drivers of reform. The COVID-19...
Promising Innovative Medicine designation for Novartis' targeted radioligand theragnostics in prostate cancer

Promising Innovative Medicine designation for Novartis’ targeted radioligand theragnostics in prostate cancer

Novartis has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted Promising Innovative Medicine (PIM) designation for 177Lu-PSMA-617, an investigational radioligand...
Positive Phase III results for Lynparza plus abiraterone in metastatic prostate cancer

Positive Phase III results for Lynparza plus abiraterone in metastatic prostate cancer

Positive high-level results from the PROpel Phase III trial have shown that AstraZeneca and MSD’s Lynparza (olaparib), in combination with abiraterone, demonstrated a significant improvement in...
Line of paper people with pills for a head. Image for Why do we need community pharmacy

Why do we need community pharmacy?

Dr Zubair Ahmed discusses the important role the community pharmacy plays in the sustainability of healthcare. Working as a GP, I saw first-hand how the...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription